Depression and coronary heart disease: 2018 position paper of the ESC working group on coronary pathophysiology and microcirculation

V Vaccarino, L Badimon, JD Bremner… - European heart …, 2020 - academic.oup.com
… risk of coronary heart disease (CHD). It is therefore not surprising that depression is highly
comorbid with CHD, being two to three times more common among patients with CHD than in …

Psychiatric and psychological interventions for depression in patients with heart disease: a scoping review

J Zambrano, CM Celano, JL Januzzi… - … of the American Heart …, 2020 - Am Heart Assoc
… Selective serotonin reuptake inhibitors appear to be safe in patients with … Selective serotonin
reuptake inhibitors may be preferred in the treatment of patients with coronary artery disease

[HTML][HTML] Depression and coronary heart disease: mechanisms, interventions, and treatments

L Xu, X Zhai, D Shi, Y Zhang - Frontiers in Psychiatry, 2024 - frontiersin.org
… Selective 5-hydroxytryptamine reuptake inhibitors (SSRIs) are the preferred antidepressants
… treatment for CHD patients with depression can be an effective and safe approach. Table 1 …

Selective serotonin reuptake inhibitors: how long is long enough?

RP Thom, JL Alexander, D Baron… - Journal of Psychiatric …, 2021 - journals.lww.com
… Based upon the chronicity and high morbidity of depressive and anxiety disorders, and
the relative safety of long-term use of SSRIs, the benefits of long-term SSRI use will likely …

Treating depression in patients with heart failure: what is (not) recommended?

C Herrmann-Lingen - European Journal of Preventive …, 2022 - academic.oup.com
… with coronary heart disease) have shown only small or even no effects … patients found the
selective serotonin reuptake inhibitors (SSRIs) sertraline and escitalopram safe for HF patients

[HTML][HTML] Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach

A Bellon, K Nguyen - World Journal of Psychiatry, 2021 - ncbi.nlm.nih.gov
… is prescribing selective serotonin reuptake inhibitors (SSRIs). … risk of coronary heart disease
in patients with depression. We … safety in older individuals at risk of coronary heart disease, …

[HTML][HTML] The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review

R Hedrick, S Korouri, E Tadros, T Darwish… - Drugs in …, 2020 - ncbi.nlm.nih.gov
serotonin reuptake inhibitors seem to be a safe treatment option for patients with depression
and … for reducing depression severity, morbidity, and mortality and improving quality of life in …

[HTML][HTML] Psychological and psychopharmacological interventions in psychocardiology

KG Kahl, B Stapel, CU Correll - Frontiers in Psychiatry, 2022 - frontiersin.org
… Presence of a heart disease should not exclude patients from … Selective serotonin reuptake
inhibitors and SNRIs are … the treatment of patients comorbid with anxiety/depression and CVD…

Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG

AA Heimisdottir, E Enger, S Morelli… - … and Cardiovascular …, 2020 - Springer
… The objective of this study was to analyse their effects on bleeding after coronary artery … for
complex coronary artery disease (CAD). Patients with severe CAD are prone to depression, 31…

Safety considerations for prescribing SSRI antidepressants to patients at increased cardiovascular risk

JK Mortensen, G Andersen - Expert Opinion on Drug Safety, 2022 - Taylor & Francis
… of selective serotonin reuptake inhibitors (… Cardiac Randomized Evaluation of Antidepressant
and Psychotherapy Efficacy) 284 patients with coronary artery disease and depression